Ratiopharm
As of the edition of 20 October 2026, Ratiopharm runs 3 drugs, 3 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 3 |
| Total | 3 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Cafedrine | none listed | 0 |
| Theodrenaline | none listed | 0 |
| Epoetin theta | none listed | 0 |
A route B row is one company at one target.
Where its trials are
- Heart and blood vessels: 1 trials led